Graham W.

Graham W. is an accomplished biopharmaceutical professional with extensive experience in gene therapy and platform development. Currently serving as Vice President of Platform Development and Site Head at Asklepios BioPharmaceutical, Inc. since January 2020, Graham focuses on creating the next generation of AAV therapeutics through innovative gene expression systems. Previous roles include Snr Director and Director of Platform Development at AskBio, where Graham led teams in developing novel technologies for gene therapy. Prior experience includes positions at Synpromics Ltd, Janssen Pharmaceutical Companies of Johnson & Johnson, DSM, FUJIFILM Diosynth Biotechnologies, and various academic roles, all contributing to a strong foundation in bioprocess optimization, protein engineering, and genetic tool development.